Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck

被引:0
作者
Anna-Maria A. De Costa
Corinne A. Schuyler
David D. Walker
M. Rita I. Young
机构
[1] Ralph H. Johnson Veterans Affairs Medical Center,Research Service (151)
[2] Medical University of South Carolina,Department of Otolaryngology, Head and Neck Surgery
[3] Medical University of South Carolina,Department of Medicine
来源
Cancer Immunology, Immunotherapy | 2012年 / 61卷
关键词
HNSCC; Premalignant; Immunoediting; Th1/Tc1 cells; Th17 cells;
D O I
暂无
中图分类号
学科分类号
摘要
While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes of HNSCC-bearing mice were found to contain a greater number of cells, including a greater number of conventional (Tconv) and regulatory (Treg) T cells, compared to cervical lymph nodes of control and premalignant lesion-bearing mice, though the Tconv cells appear to be less proliferative and the Treg cells appear to be less suppressive at the HNSCC stage. Premalignant lesion-bearing mouse lymph nodes consist of a greater percentage of Tconv cells expressing markers for activation, memory, and exhaustion compared to both control and HNSCC-bearing mice. Also, lymph nodes’ cells from both premalignant lesion-bearing and HNSCC-bearing mice include increased levels of Th1, Tc1, and Th17 cells, with no differences in levels of Th2 cells, compared to control mice. The data show that while there is the expected increase in immunosuppressive Tregs in lymph nodes when HNSCC is present, there is also an unexpected increase in immune populations usually associated with a beneficial antitumor response, including Tconv cells and Th1 and Tc1 cells. In addition, the results demonstrate that the premalignant stage of HNSCC development is associated with a robust immune response involving an increase in inflammatory Th1, Tc1, and Th17 cells.
引用
收藏
页码:927 / 939
页数:12
相关论文
共 50 条
  • [41] Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma
    Pries, R
    Thiel, A
    Brocks, C
    Wollenberg, B
    IN VIVO, 2006, 20 (01): : 45 - 48
  • [42] Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma
    Shao, Peng
    Hu, Wei-Wei
    Shi, Xin-lian
    Shu, Ming-yang
    Li, Dong-Ya
    Zhou, Tingting
    Zhao, Qi-Tao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (02)
  • [43] Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
    Peitzsch, Claudia
    Nathansen, Jacqueline
    Schniewind, Sebastian, I
    Schwarz, Franziska
    Dubrovska, Anna
    CANCERS, 2019, 11 (05)
  • [44] TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
    He, Yaodong
    Li, Yunshan
    Xiang, Junwei
    Huang, Xu
    Zhao, Mingyu
    Wang, Yuanyin
    Chen, Ran
    FRONTIERS IN GENETICS, 2022, 13
  • [45] Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
    Yang, Zhi-Min
    Liao, Bing
    Yang, Si-Si
    Su, Tong
    Zhang, Jing
    Wang, Wei-Ming
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [46] Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
    Su, Kaixin
    Zhou, Zekun
    Yi, Qiao
    Liu, Junjie
    Luo, Tiao
    Cui, Xinyan
    Zhang, Haixia
    FRONTIERS IN GENETICS, 2022, 13
  • [47] CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma
    Zhang, Zhichao
    Ren, Xusheng
    Wang, Yiling
    Liu, Ping
    Lin, Peng
    Jin, Shumei
    Xu, Chao
    BMC ORAL HEALTH, 2024, 24 (01):
  • [48] Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
    Idel, Christian
    Ribbat-Idel, Julika
    Klapper, Luise
    Krupar, Rosemarie
    Bruchhage, Karl-Ludwig
    Dreyer, Eva
    Rades, Dirk
    Polasky, Christina
    Offermann, Anne
    Kirfel, Jutta
    Perner, Sven
    Wollenberg, Barbara
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] USP5 Promotes Head and Neck Squamous Cell Carcinoma Progression via mTOR Signaling Pathway
    Xiong, Ni
    Wang, Yue
    Jiang, Junhong
    CANCER MEDICINE, 2025, 14 (05):
  • [50] TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
    Zhou, Ge
    Liu, Zhiyi
    Myers, Jeffrey N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (12) : 2682 - 2692